Skip to main content
Top
Published in: Current Urology Reports 9/2014

01-09-2014 | Urothelial Cancer (A Sagalowsky, Section Editor)

Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?

Authors: Stephanie P. Chen, Joseph C. Liao

Published in: Current Urology Reports | Issue 9/2014

Login to get access

Abstract

Urothelial carcinoma of the bladder and upper tract pose significant diagnostic and therapeutic challenges. White light endoscopy plays a central role in the management of urothelial carcinoma but has several well-recognized shortcomings. New optical imaging technologies may improve diagnostic accuracy, enhance local cancer control, and better stratify treatment options. Confocal laser endomicroscopy enables dynamic imaging of the cellular structures below the mucosal surface and holds promise in providing real time optical diagnosis and grading of urothelial carcinoma. A variety of imaging probes are available that are compatible with the full spectrum of cystoscopes and ureteroscopes. We review the underlying principles and technique of confocal laser endomicroscopy in the urinary tract, with emphasis on specific application towards urothelial carcinoma. While the available data are largely related to urothelial carcinoma of the bladder, the lessons learned are directly applicable to the upper tract, where the clinical needs are significant. Ongoing efforts to optimize this technology offer an exciting glimpse into future advances in optical imaging and intraoperative image guidance.
Literature
1.
go back to reference U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 incidence and mortality web-based report. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2013). U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2010 incidence and mortality web-based report. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2013).
2.
3.
go back to reference Kirkali Z et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66:4–34.PubMedCrossRef Kirkali Z et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66:4–34.PubMedCrossRef
5.
go back to reference Sylvester RJ et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–77.PubMedCrossRef Sylvester RJ et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49:466–77.PubMedCrossRef
6.
go back to reference Cauberg Evelyne CC, de la Rosette JJMCH, de Reijke TM. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol IJU J Urol Soc India. 2011;27:245–51.CrossRef Cauberg Evelyne CC, de la Rosette JJMCH, de Reijke TM. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol IJU J Urol Soc India. 2011;27:245–51.CrossRef
7.
go back to reference Rouprêt M et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRef Rouprêt M et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRef
8.
go back to reference Hall MC et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594–601.PubMedCrossRef Hall MC et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594–601.PubMedCrossRef
9.
go back to reference Linton KD, Catto JW. Upper tract urothelial carcinoma. J Clin Urol. 2013;6:272–9. Linton KD, Catto JW. Upper tract urothelial carcinoma. J Clin Urol. 2013;6:272–9.
10.
go back to reference Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:130–6.PubMedCrossRef Azémar M-D, Comperat E, Richard F, Cussenot O, Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol. 2011;29:130–6.PubMedCrossRef
11.
go back to reference Lee CSD, Yoon CY, Witjes JA. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. BJU Int. 2008;102:1228–33.PubMedCrossRef Lee CSD, Yoon CY, Witjes JA. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology. BJU Int. 2008;102:1228–33.PubMedCrossRef
12.
13.•
go back to reference Wu K et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology. 2011;78:225–31. This paper describes the suggested optical diagnostic criteria for normal urothelium, benign inflammatory urothelium, low grade urothelial carcinoma, and high grade urothelial carcinoma.PubMedCentralPubMedCrossRef Wu K et al. Dynamic real-time microscopy of the urinary tract using confocal laser endomicroscopy. Urology. 2011;78:225–31. This paper describes the suggested optical diagnostic criteria for normal urothelium, benign inflammatory urothelium, low grade urothelial carcinoma, and high grade urothelial carcinoma.PubMedCentralPubMedCrossRef
14.
go back to reference Schmidbauer J et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171:135–8.PubMedCrossRef Schmidbauer J et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol. 2004;171:135–8.PubMedCrossRef
15.
go back to reference Fradet Y et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178:68–73. discussion 73.PubMedCrossRef Fradet Y et al. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007;178:68–73. discussion 73.PubMedCrossRef
16.
go back to reference Jocham D et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174:862–6. discussion 866.PubMedCrossRef Jocham D et al. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol. 2005;174:862–6. discussion 866.PubMedCrossRef
17.
go back to reference Kolozsy Z. Histopathological ‘self control’ in transurethral resection of bladder tumours. Br J Urol. 1991;67:162–4.PubMedCrossRef Kolozsy Z. Histopathological ‘self control’ in transurethral resection of bladder tumours. Br J Urol. 1991;67:162–4.PubMedCrossRef
18.
go back to reference Babjuk M, Soukup V, Petrík R, Jirsa M, Dvorácek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96:798–802.PubMedCrossRef Babjuk M, Soukup V, Petrík R, Jirsa M, Dvorácek J. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer. BJU Int. 2005;96:798–802.PubMedCrossRef
19.
go back to reference Daniltchenko DI et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174:2129–33. discussion 2133.PubMedCrossRef Daniltchenko DI et al. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol. 2005;174:2129–33. discussion 2133.PubMedCrossRef
20.
go back to reference Klän R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146:316–8.PubMed Klän R, Loy V, Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol. 1991;146:316–8.PubMed
21.
go back to reference Brausi M et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–31.PubMedCrossRef Brausi M et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–31.PubMedCrossRef
22.
go back to reference Margulis V et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33.PubMedCrossRef Margulis V et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224–33.PubMedCrossRef
23.
go back to reference Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1166–70.PubMedCrossRef Straub J, Strittmatter F, Karl A, Stief CG, Tritschler S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31:1166–70.PubMedCrossRef
24.
go back to reference Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012;79:615–9.PubMedCrossRef Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2012;79:615–9.PubMedCrossRef
25.
go back to reference Smith AK et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–6.PubMedCrossRef Smith AK et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–6.PubMedCrossRef
26.
go back to reference Tavora F et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.PubMedCrossRef Tavora F et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol. 2009;33:1540–6.PubMedCrossRef
27.
go back to reference Cutress ML et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110:614–28.PubMedCrossRef Cutress ML et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110:614–28.PubMedCrossRef
28.
go back to reference Elliott DS, Segura JW, Lightner D, Patterson DE, Blute ML. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.PubMedCrossRef Elliott DS, Segura JW, Lightner D, Patterson DE, Blute ML. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.PubMedCrossRef
29.
go back to reference Gadzinski AJ, Roberts WW, Faerber GJ, Wolf Jr JS. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol. 2010;183:2148–53.PubMedCrossRef Gadzinski AJ, Roberts WW, Faerber GJ, Wolf Jr JS. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol. 2010;183:2148–53.PubMedCrossRef
30.
go back to reference Lopez A, Liao JC. Emerging endoscopic imaging technologies for bladder cancer detection. Curr Urol Rep. 2014;15:406.PubMedCrossRef Lopez A, Liao JC. Emerging endoscopic imaging technologies for bladder cancer detection. Curr Urol Rep. 2014;15:406.PubMedCrossRef
31.•
go back to reference Sonn GA et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182:1299–305. This paper was the initial feasibility study of in vivo confocal laser endomicroscopy in the urinary tract.PubMedCrossRef Sonn GA et al. Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009;182:1299–305. This paper was the initial feasibility study of in vivo confocal laser endomicroscopy in the urinary tract.PubMedCrossRef
32.
go back to reference Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139:388–92. 392.e1–2.PubMedCrossRef Neumann H, Kiesslich R, Wallace MB, Neurath MF. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139:388–92. 392.e1–2.PubMedCrossRef
33.
go back to reference Thiberville L, Salaün M. Bronchoscopic advances: on the way to the cells. Respir Int Rev Thorac Dis. 2010;79:441–9. Thiberville L, Salaün M. Bronchoscopic advances: on the way to the cells. Respir Int Rev Thorac Dis. 2010;79:441–9.
34.
go back to reference Sonn GA et al. Fibered confocal microscopy of bladder tumors: an ex vivo study. J Endourol Endourol Soc. 2009;23:197–201.CrossRef Sonn GA et al. Fibered confocal microscopy of bladder tumors: an ex vivo study. J Endourol Endourol Soc. 2009;23:197–201.CrossRef
35.•
go back to reference Chang TC, Liu J-J, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;e4409. doi:10.3791/4409. This on-line video paper demonstrates a step-by-step approach of confocal laser endomicroscopy in the lower urinary tract. Chang TC, Liu J-J, Liao JC. Probe-based confocal laser endomicroscopy of the urinary tract: the technique. J Vis Exp JoVE. 2013;e4409. doi:10.​3791/​4409. This on-line video paper demonstrates a step-by-step approach of confocal laser endomicroscopy in the lower urinary tract.
36.
go back to reference Wallace MB et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 2010;31:548–52.PubMedCrossRef Wallace MB et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther. 2010;31:548–52.PubMedCrossRef
37.
go back to reference Becker V et al. High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). Gastrointest Endosc. 2007;66:1001–7.PubMedCrossRef Becker V et al. High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video). Gastrointest Endosc. 2007;66:1001–7.PubMedCrossRef
38.•
go back to reference Chang TC et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol Endourol Soc. 2013;27:598–603. This paper describes the interobserver agreement of confocal laser endomicroscopy of bladder lesions and provides an updated optical diagnostic criteria.CrossRef Chang TC et al. Interobserver agreement of confocal laser endomicroscopy for bladder cancer. J Endourol Endourol Soc. 2013;27:598–603. This paper describes the interobserver agreement of confocal laser endomicroscopy of bladder lesions and provides an updated optical diagnostic criteria.CrossRef
39.
go back to reference Aron M et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol. 2013;37:1815–23.PubMedCrossRef Aron M et al. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia. Am J Surg Pathol. 2013;37:1815–23.PubMedCrossRef
40.
go back to reference Wallace MB et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett’s esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc. 2010;72:19–24.PubMedCentralPubMedCrossRef Wallace MB et al. Preliminary accuracy and interobserver agreement for the detection of intraepithelial neoplasia in Barrett’s esophagus with probe-based confocal laser endomicroscopy. Gastrointest Endosc. 2010;72:19–24.PubMedCentralPubMedCrossRef
41.
go back to reference Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37:360–3.PubMed
42.
go back to reference Kuiper T, Kiesslich R, Ponsioen C, Fockens P, Dekker E. The learning curve, accuracy, and interobserver agreement of endoscope-based confocal laser endomicroscopy for the differentiation of colorectal lesions. Gastrointest Endosc. 2012;75:1211–7.PubMedCrossRef Kuiper T, Kiesslich R, Ponsioen C, Fockens P, Dekker E. The learning curve, accuracy, and interobserver agreement of endoscope-based confocal laser endomicroscopy for the differentiation of colorectal lesions. Gastrointest Endosc. 2012;75:1211–7.PubMedCrossRef
43.
go back to reference Gómez V et al. Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy. 2010;42:286–91.PubMedCrossRef Gómez V et al. Interobserver agreement and accuracy among international experts with probe-based confocal laser endomicroscopy in predicting colorectal neoplasia. Endoscopy. 2010;42:286–91.PubMedCrossRef
44.
go back to reference Lee YC et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.PubMedCentralPubMedCrossRef Lee YC et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.PubMedCentralPubMedCrossRef
45.
go back to reference Kiesslich R et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006;4:979–87. Kiesslich R et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2006;4:979–87.
46.
go back to reference Gaddam S et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2011;106:1961–9.PubMedCrossRef Gaddam S et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2011;106:1961–9.PubMedCrossRef
47.
go back to reference Bui D, Mach KE, Lopez A, Liu JJ, Chang T, Lavelle J, et al. Optical biopsy of upper tract urothelial carcinoma with confocal laser endomicroscopy. Eur Urol. 2014;13:e630.CrossRef Bui D, Mach KE, Lopez A, Liu JJ, Chang T, Lavelle J, et al. Optical biopsy of upper tract urothelial carcinoma with confocal laser endomicroscopy. Eur Urol. 2014;13:e630.CrossRef
48.
go back to reference André B, Vercauteren T, Buchner AM, Wallace MB, Ayache N. A smart atlas for endomicroscopy using automated video retrieval. Med Image Anal. 2011;15:460–76.PubMedCrossRef André B, Vercauteren T, Buchner AM, Wallace MB, Ayache N. A smart atlas for endomicroscopy using automated video retrieval. Med Image Anal. 2011;15:460–76.PubMedCrossRef
49.
go back to reference André B et al. Software for automated classification of probe-based confocal laser endomicroscopy videos of colorectal polyps. World J Gastroenterol WJG. 2012;18:5560–9.CrossRef André B et al. Software for automated classification of probe-based confocal laser endomicroscopy videos of colorectal polyps. World J Gastroenterol WJG. 2012;18:5560–9.CrossRef
50.
51.
go back to reference Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol. 2001;19:327–31.PubMedCrossRef Becker A et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol. 2001;19:327–31.PubMedCrossRef
52.
go back to reference Sturm MB et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med. 2013;5:184ra61.PubMedCrossRef Sturm MB et al. Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med. 2013;5:184ra61.PubMedCrossRef
53.
54.
go back to reference Thekkek N et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett’s-associated neoplasia during confocal imaging. Technol Cancer Res Treat. 2011;10:431–41.PubMedCentralPubMed Thekkek N et al. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett’s-associated neoplasia during confocal imaging. Technol Cancer Res Treat. 2011;10:431–41.PubMedCentralPubMed
Metadata
Title
Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?
Authors
Stephanie P. Chen
Joseph C. Liao
Publication date
01-09-2014
Publisher
Springer US
Published in
Current Urology Reports / Issue 9/2014
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0437-y

Other articles of this Issue 9/2014

Current Urology Reports 9/2014 Go to the issue

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

UTIs in Patients with Neurogenic Bladder

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Management of Refractory OAB in the Non-Neurogenic Patient

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Evaluation and Management of Post-Transurethral Resection of the Prostate Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Bladder Outlet Obstruction in Women: Functional Causes

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

A Review of Lower Urinary Tract Symptoms in Patients with Parkinson’s Disease

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

The Evaluation and Management of Persistent Nocturia